Oncology Pharmaceuticals Comprehensive Study by Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), Application (Breast Cancer, Blood Cancer, Colorectal, Melanoma, Others), Form (Tablets, Capsules, Others), Distribution Channel (Online, Offline (Hospital Pharmacy, Retail Pharmacy)) Players and Region - Global Market Outlook to 2025

Report Objectives / Segmentation Covered

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy
• Others

• Breast Cancer
• Blood Cancer
• Colorectal
• Melanoma
• Others

• Tablets
• Capsules
• Others

• Online
• Offline [Hospital Pharmacy, Retail Pharmacy]

• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • Italy
  • United Kingdom
  • Netherlands
  • Switzerland
  • Rest of Europe
• MEA
  • Middle East
  • Africa
• North America
  • United States
  • Canada
  • Mexico

• 1. Market Overview
  • 1.1. Introduction
  • 1.2. Scope/Objective of the Study
    • 1.2.1. Research Objective
• 2. Executive Summary
  • 2.1. Introduction
• 3. Market Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Rising Spending On Therapeutic and Supportive Care for Cancer
    • 3.2.2. Increase in Treatment Options That Have Helped To Lengthen Lives
  • 3.3. Market Challenges
    • 3.3.1. High Costs of Oncology Therapeutics and Complexity in Cancer Treatments
  • 3.4. Market Trends
    • 3.4.1. Rapid Uptake of Immuno-Oncology Drugs
• 4. Market Factor Analysis
  • 4.1. Porters Five Forces
  • 4.2. Supply/Value Chain
  • 4.3. PESTEL analysis
  • 4.4. Market Entropy
  • 4.5. Patent/Trademark Analysis
• 5. Global Oncology Pharmaceuticals, by Type, Application, Form, Distribution Channel and Region (value, volume and price ) (2014-2019)
  • 5.1. Introduction
  • 5.2. Global Oncology Pharmaceuticals (Value)
    • 5.2.1. Global Oncology Pharmaceuticals by: Type (Value)
      • 5.2.1.1. Chemotherapy
      • 5.2.1.2. Targeted Therapy
      • 5.2.1.3. Immunotherapy
      • 5.2.1.4. Hormonal Therapy
      • 5.2.1.5. Others
    • 5.2.2. Global Oncology Pharmaceuticals by: Application (Value)
      • 5.2.2.1. Breast Cancer
      • 5.2.2.2. Blood Cancer
      • 5.2.2.3. Colorectal
      • 5.2.2.4. Melanoma
      • 5.2.2.5. Others
    • 5.2.3. Global Oncology Pharmaceuticals by: Form (Value)
      • 5.2.3.1. Tablets
      • 5.2.3.2. Capsules
      • 5.2.3.3. Others
    • 5.2.4. Global Oncology Pharmaceuticals by: Distribution Channel (Value)
      • 5.2.4.1. Online
      • 5.2.4.2. Offline [Hospital Pharmacy, Retail Pharmacy]
    • 5.2.5. Global Oncology Pharmaceuticals Region
      • 5.2.5.1. South America
        • 5.2.5.1.1. Brazil
        • 5.2.5.1.2. Argentina
        • 5.2.5.1.3. Rest of South America
      • 5.2.5.2. Asia Pacific
        • 5.2.5.2.1. China
        • 5.2.5.2.2. Japan
        • 5.2.5.2.3. India
        • 5.2.5.2.4. South Korea
        • 5.2.5.2.5. Taiwan
        • 5.2.5.2.6. Australia
        • 5.2.5.2.7. Rest of Asia-Pacific
      • 5.2.5.3. Europe
        • 5.2.5.3.1. Germany
        • 5.2.5.3.2. France
        • 5.2.5.3.3. Italy
        • 5.2.5.3.4. United Kingdom
        • 5.2.5.3.5. Netherlands
        • 5.2.5.3.6. Switzerland
        • 5.2.5.3.7. Rest of Europe
      • 5.2.5.4. MEA
        • 5.2.5.4.1. Middle East
        • 5.2.5.4.2. Africa
      • 5.2.5.5. North America
        • 5.2.5.5.1. United States
        • 5.2.5.5.2. Canada
        • 5.2.5.5.3. Mexico
  • 5.3. Global Oncology Pharmaceuticals (Volume)
    • 5.3.1. Global Oncology Pharmaceuticals by: Type (Volume)
      • 5.3.1.1. Chemotherapy
      • 5.3.1.2. Targeted Therapy
      • 5.3.1.3. Immunotherapy
      • 5.3.1.4. Hormonal Therapy
      • 5.3.1.5. Others
    • 5.3.2. Global Oncology Pharmaceuticals by: Application (Volume)
      • 5.3.2.1. Breast Cancer
      • 5.3.2.2. Blood Cancer
      • 5.3.2.3. Colorectal
      • 5.3.2.4. Melanoma
      • 5.3.2.5. Others
    • 5.3.3. Global Oncology Pharmaceuticals by: Form (Volume)
      • 5.3.3.1. Tablets
      • 5.3.3.2. Capsules
      • 5.3.3.3. Others
    • 5.3.4. Global Oncology Pharmaceuticals by: Distribution Channel (Volume)
      • 5.3.4.1. Online
      • 5.3.4.2. Offline [Hospital Pharmacy, Retail Pharmacy]
    • 5.3.5. Global Oncology Pharmaceuticals Region
      • 5.3.5.1. South America
        • 5.3.5.1.1. Brazil
        • 5.3.5.1.2. Argentina
        • 5.3.5.1.3. Rest of South America
      • 5.3.5.2. Asia Pacific
        • 5.3.5.2.1. China
        • 5.3.5.2.2. Japan
        • 5.3.5.2.3. India
        • 5.3.5.2.4. South Korea
        • 5.3.5.2.5. Taiwan
        • 5.3.5.2.6. Australia
        • 5.3.5.2.7. Rest of Asia-Pacific
      • 5.3.5.3. Europe
        • 5.3.5.3.1. Germany
        • 5.3.5.3.2. France
        • 5.3.5.3.3. Italy
        • 5.3.5.3.4. United Kingdom
        • 5.3.5.3.5. Netherlands
        • 5.3.5.3.6. Switzerland
        • 5.3.5.3.7. Rest of Europe
      • 5.3.5.4. MEA
        • 5.3.5.4.1. Middle East
        • 5.3.5.4.2. Africa
      • 5.3.5.5. North America
        • 5.3.5.5.1. United States
        • 5.3.5.5.2. Canada
        • 5.3.5.5.3. Mexico
  • 5.4. Global Oncology Pharmaceuticals (Price)
    • 5.4.1. Global Oncology Pharmaceuticals by: Type (Price)
• 6. Oncology Pharmaceuticals: Manufacturers/Players Analysis
  • 6.1. Competitive Landscape
    • 6.1.1. Market Share Analysis
      • 6.1.1.1. Top 3
      • 6.1.1.2. Top 5
  • 6.2. Peer Group Analysis (2019)
  • 6.3. BCG Matrix
  • 6.4. Company Profile
    • 6.4.1. Roche Holding AG (Switzerland)
      • 6.4.1.1. Business Overview
      • 6.4.1.2. Products/Services Offerings
      • 6.4.1.3. Financial Analysis
      • 6.4.1.4. SWOT Analysis
    • 6.4.2. Eli Lilly and Company (United States)
      • 6.4.2.1. Business Overview
      • 6.4.2.2. Products/Services Offerings
      • 6.4.2.3. Financial Analysis
      • 6.4.2.4. SWOT Analysis
    • 6.4.3. AbbVie, Inc. (United States)
      • 6.4.3.1. Business Overview
      • 6.4.3.2. Products/Services Offerings
      • 6.4.3.3. Financial Analysis
      • 6.4.3.4. SWOT Analysis
    • 6.4.4. Amgen Inc. (United States)
      • 6.4.4.1. Business Overview
      • 6.4.4.2. Products/Services Offerings
      • 6.4.4.3. Financial Analysis
      • 6.4.4.4. SWOT Analysis
    • 6.4.5. AstraZeneca plc. (United Kingdom)
      • 6.4.5.1. Business Overview
      • 6.4.5.2. Products/Services Offerings
      • 6.4.5.3. Financial Analysis
      • 6.4.5.4. SWOT Analysis
    • 6.4.6. Celgene Corporation (United States)
      • 6.4.6.1. Business Overview
      • 6.4.6.2. Products/Services Offerings
      • 6.4.6.3. Financial Analysis
      • 6.4.6.4. SWOT Analysis
    • 6.4.7. Sinopharm Group (China)
      • 6.4.7.1. Business Overview
      • 6.4.7.2. Products/Services Offerings
      • 6.4.7.3. Financial Analysis
      • 6.4.7.4. SWOT Analysis
    • 6.4.8. Shanghai Pharmaceuticals Holding Co., Ltd. (China)
      • 6.4.8.1. Business Overview
      • 6.4.8.2. Products/Services Offerings
      • 6.4.8.3. Financial Analysis
      • 6.4.8.4. SWOT Analysis
    • 6.4.9. Gilead Sciences (United States)
      • 6.4.9.1. Business Overview
      • 6.4.9.2. Products/Services Offerings
      • 6.4.9.3. Financial Analysis
      • 6.4.9.4. SWOT Analysis
    • 6.4.10. CSPC pharmaceutical (China)
      • 6.4.10.1. Business Overview
      • 6.4.10.2. Products/Services Offerings
      • 6.4.10.3. Financial Analysis
      • 6.4.10.4. SWOT Analysis
    • 6.4.11. Jiangsu Hengrui Medicine (China)
      • 6.4.11.1. Business Overview
      • 6.4.11.2. Products/Services Offerings
      • 6.4.11.3. Financial Analysis
      • 6.4.11.4. SWOT Analysis
    • 6.4.12. Shanghai Fosun Pharmaceutical (China)
      • 6.4.12.1. Business Overview
      • 6.4.12.2. Products/Services Offerings
      • 6.4.12.3. Financial Analysis
      • 6.4.12.4. SWOT Analysis
    • 6.4.13. Guangzhou Hanfang Pharmaceutical Co., Ltd (China)
      • 6.4.13.1. Business Overview
      • 6.4.13.2. Products/Services Offerings
      • 6.4.13.3. Financial Analysis
      • 6.4.13.4. SWOT Analysis
    • 6.4.14. China Meheco Group Co., Ltd (China)
      • 6.4.14.1. Business Overview
      • 6.4.14.2. Products/Services Offerings
      • 6.4.14.3. Financial Analysis
      • 6.4.14.4. SWOT Analysis
    • 6.4.15. BeiGene (China)
      • 6.4.15.1. Business Overview
      • 6.4.15.2. Products/Services Offerings
      • 6.4.15.3. Financial Analysis
      • 6.4.15.4. SWOT Analysis
• 7. Global Oncology Pharmaceuticals Sale, by Type, Application, Form, Distribution Channel and Region (value, volume and price ) (2020-2025)
  • 7.1. Introduction
  • 7.2. Global Oncology Pharmaceuticals (Value)
    • 7.2.1. Global Oncology Pharmaceuticals by: Type (Value)
      • 7.2.1.1. Chemotherapy
      • 7.2.1.2. Targeted Therapy
      • 7.2.1.3. Immunotherapy
      • 7.2.1.4. Hormonal Therapy
      • 7.2.1.5. Others
    • 7.2.2. Global Oncology Pharmaceuticals by: Application (Value)
      • 7.2.2.1. Breast Cancer
      • 7.2.2.2. Blood Cancer
      • 7.2.2.3. Colorectal
      • 7.2.2.4. Melanoma
      • 7.2.2.5. Others
    • 7.2.3. Global Oncology Pharmaceuticals by: Form (Value)
      • 7.2.3.1. Tablets
      • 7.2.3.2. Capsules
      • 7.2.3.3. Others
    • 7.2.4. Global Oncology Pharmaceuticals by: Distribution Channel (Value)
      • 7.2.4.1. Online
      • 7.2.4.2. Offline [Hospital Pharmacy, Retail Pharmacy]
    • 7.2.5. Global Oncology Pharmaceuticals Region
      • 7.2.5.1. South America
        • 7.2.5.1.1. Brazil
        • 7.2.5.1.2. Argentina
        • 7.2.5.1.3. Rest of South America
      • 7.2.5.2. Asia Pacific
        • 7.2.5.2.1. China
        • 7.2.5.2.2. Japan
        • 7.2.5.2.3. India
        • 7.2.5.2.4. South Korea
        • 7.2.5.2.5. Taiwan
        • 7.2.5.2.6. Australia
        • 7.2.5.2.7. Rest of Asia-Pacific
      • 7.2.5.3. Europe
        • 7.2.5.3.1. Germany
        • 7.2.5.3.2. France
        • 7.2.5.3.3. Italy
        • 7.2.5.3.4. United Kingdom
        • 7.2.5.3.5. Netherlands
        • 7.2.5.3.6. Switzerland
        • 7.2.5.3.7. Rest of Europe
      • 7.2.5.4. MEA
        • 7.2.5.4.1. Middle East
        • 7.2.5.4.2. Africa
      • 7.2.5.5. North America
        • 7.2.5.5.1. United States
        • 7.2.5.5.2. Canada
        • 7.2.5.5.3. Mexico
  • 7.3. Global Oncology Pharmaceuticals (Volume)
    • 7.3.1. Global Oncology Pharmaceuticals by: Type (Volume)
      • 7.3.1.1. Chemotherapy
      • 7.3.1.2. Targeted Therapy
      • 7.3.1.3. Immunotherapy
      • 7.3.1.4. Hormonal Therapy
      • 7.3.1.5. Others
    • 7.3.2. Global Oncology Pharmaceuticals by: Application (Volume)
      • 7.3.2.1. Breast Cancer
      • 7.3.2.2. Blood Cancer
      • 7.3.2.3. Colorectal
      • 7.3.2.4. Melanoma
      • 7.3.2.5. Others
    • 7.3.3. Global Oncology Pharmaceuticals by: Form (Volume)
      • 7.3.3.1. Tablets
      • 7.3.3.2. Capsules
      • 7.3.3.3. Others
    • 7.3.4. Global Oncology Pharmaceuticals by: Distribution Channel (Volume)
      • 7.3.4.1. Online
      • 7.3.4.2. Offline [Hospital Pharmacy, Retail Pharmacy]
    • 7.3.5. Global Oncology Pharmaceuticals Region
      • 7.3.5.1. South America
        • 7.3.5.1.1. Brazil
        • 7.3.5.1.2. Argentina
        • 7.3.5.1.3. Rest of South America
      • 7.3.5.2. Asia Pacific
        • 7.3.5.2.1. China
        • 7.3.5.2.2. Japan
        • 7.3.5.2.3. India
        • 7.3.5.2.4. South Korea
        • 7.3.5.2.5. Taiwan
        • 7.3.5.2.6. Australia
        • 7.3.5.2.7. Rest of Asia-Pacific
      • 7.3.5.3. Europe
        • 7.3.5.3.1. Germany
        • 7.3.5.3.2. France
        • 7.3.5.3.3. Italy
        • 7.3.5.3.4. United Kingdom
        • 7.3.5.3.5. Netherlands
        • 7.3.5.3.6. Switzerland
        • 7.3.5.3.7. Rest of Europe
      • 7.3.5.4. MEA
        • 7.3.5.4.1. Middle East
        • 7.3.5.4.2. Africa
      • 7.3.5.5. North America
        • 7.3.5.5.1. United States
        • 7.3.5.5.2. Canada
        • 7.3.5.5.3. Mexico
  • 7.4. Global Oncology Pharmaceuticals (Price)
    • 7.4.1. Global Oncology Pharmaceuticals by: Type (Price)
• 8. Appendix
  • 8.1. Acronyms
• 9. Methodology and Data Source
  • 9.1. Methodology/Research Approach
    • 9.1.1. Research Programs/Design
    • 9.1.2. Market Size Estimation
    • 9.1.3. Market Breakdown and Data Triangulation
  • 9.2. Data Source
    • 9.2.1. Secondary Sources
    • 9.2.2. Primary Sources
  • 9.3. Disclaimer

• Table 1. Oncology Pharmaceuticals: by Type(USD Million)
• Table 2. Oncology Pharmaceuticals Chemotherapy , by Region USD Million (2014-2019)
• Table 3. Oncology Pharmaceuticals Targeted Therapy , by Region USD Million (2014-2019)
• Table 4. Oncology Pharmaceuticals Immunotherapy , by Region USD Million (2014-2019)
• Table 5. Oncology Pharmaceuticals Hormonal Therapy , by Region USD Million (2014-2019)
• Table 6. Oncology Pharmaceuticals Others , by Region USD Million (2014-2019)
• Table 7. Oncology Pharmaceuticals: by Application(USD Million)
• Table 8. Oncology Pharmaceuticals Breast Cancer , by Region USD Million (2014-2019)
• Table 9. Oncology Pharmaceuticals Blood Cancer , by Region USD Million (2014-2019)
• Table 10. Oncology Pharmaceuticals Colorectal , by Region USD Million (2014-2019)
• Table 11. Oncology Pharmaceuticals Melanoma , by Region USD Million (2014-2019)
• Table 12. Oncology Pharmaceuticals Others , by Region USD Million (2014-2019)
• Table 13. Oncology Pharmaceuticals: by Form(USD Million)
• Table 14. Oncology Pharmaceuticals Tablets , by Region USD Million (2014-2019)
• Table 15. Oncology Pharmaceuticals Capsules , by Region USD Million (2014-2019)
• Table 16. Oncology Pharmaceuticals Others , by Region USD Million (2014-2019)
• Table 17. Oncology Pharmaceuticals: by Distribution Channel(USD Million)
• Table 18. Oncology Pharmaceuticals Online , by Region USD Million (2014-2019)
• Table 19. Oncology Pharmaceuticals Offline [Hospital Pharmacy, Retail Pharmacy] , by Region USD Million (2014-2019)
• Table 20. South America Oncology Pharmaceuticals, by Country USD Million (2014-2019)
• Table 21. South America Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 22. South America Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 23. South America Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 24. South America Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 25. Brazil Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 26. Brazil Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 27. Brazil Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 28. Brazil Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 29. Argentina Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 30. Argentina Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 31. Argentina Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 32. Argentina Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 33. Rest of South America Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 34. Rest of South America Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 35. Rest of South America Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 36. Rest of South America Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 37. Asia Pacific Oncology Pharmaceuticals, by Country USD Million (2014-2019)
• Table 38. Asia Pacific Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 39. Asia Pacific Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 40. Asia Pacific Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 41. Asia Pacific Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 42. China Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 43. China Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 44. China Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 45. China Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 46. Japan Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 47. Japan Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 48. Japan Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 49. Japan Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 50. India Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 51. India Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 52. India Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 53. India Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 54. South Korea Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 55. South Korea Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 56. South Korea Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 57. South Korea Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 58. Taiwan Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 59. Taiwan Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 60. Taiwan Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 61. Taiwan Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 62. Australia Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 63. Australia Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 64. Australia Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 65. Australia Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 66. Rest of Asia-Pacific Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 67. Rest of Asia-Pacific Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 68. Rest of Asia-Pacific Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 69. Rest of Asia-Pacific Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 70. Europe Oncology Pharmaceuticals, by Country USD Million (2014-2019)
• Table 71. Europe Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 72. Europe Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 73. Europe Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 74. Europe Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 75. Germany Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 76. Germany Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 77. Germany Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 78. Germany Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 79. France Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 80. France Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 81. France Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 82. France Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 83. Italy Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 84. Italy Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 85. Italy Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 86. Italy Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 87. United Kingdom Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 88. United Kingdom Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 89. United Kingdom Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 90. United Kingdom Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 91. Netherlands Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 92. Netherlands Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 93. Netherlands Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 94. Netherlands Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 95. Switzerland Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 96. Switzerland Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 97. Switzerland Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 98. Switzerland Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 99. Rest of Europe Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 100. Rest of Europe Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 101. Rest of Europe Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 102. Rest of Europe Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 103. MEA Oncology Pharmaceuticals, by Country USD Million (2014-2019)
• Table 104. MEA Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 105. MEA Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 106. MEA Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 107. MEA Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 108. Middle East Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 109. Middle East Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 110. Middle East Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 111. Middle East Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 112. Africa Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 113. Africa Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 114. Africa Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 115. Africa Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 116. North America Oncology Pharmaceuticals, by Country USD Million (2014-2019)
• Table 117. North America Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 118. North America Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 119. North America Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 120. North America Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 121. United States Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 122. United States Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 123. United States Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 124. United States Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 125. Canada Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 126. Canada Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 127. Canada Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 128. Canada Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 129. Mexico Oncology Pharmaceuticals, by Type USD Million (2014-2019)
• Table 130. Mexico Oncology Pharmaceuticals, by Application USD Million (2014-2019)
• Table 131. Mexico Oncology Pharmaceuticals, by Form USD Million (2014-2019)
• Table 132. Mexico Oncology Pharmaceuticals, by Distribution Channel USD Million (2014-2019)
• Table 133. Oncology Pharmaceuticals Sales: by Type(K Tons)
• Table 134. Oncology Pharmaceuticals Sales Chemotherapy , by Region K Tons (2014-2019)
• Table 135. Oncology Pharmaceuticals Sales Targeted Therapy , by Region K Tons (2014-2019)
• Table 136. Oncology Pharmaceuticals Sales Immunotherapy , by Region K Tons (2014-2019)
• Table 137. Oncology Pharmaceuticals Sales Hormonal Therapy , by Region K Tons (2014-2019)
• Table 138. Oncology Pharmaceuticals Sales Others , by Region K Tons (2014-2019)
• Table 139. Oncology Pharmaceuticals Sales: by Application(K Tons)
• Table 140. Oncology Pharmaceuticals Sales Breast Cancer , by Region K Tons (2014-2019)
• Table 141. Oncology Pharmaceuticals Sales Blood Cancer , by Region K Tons (2014-2019)
• Table 142. Oncology Pharmaceuticals Sales Colorectal , by Region K Tons (2014-2019)
• Table 143. Oncology Pharmaceuticals Sales Melanoma , by Region K Tons (2014-2019)
• Table 144. Oncology Pharmaceuticals Sales Others , by Region K Tons (2014-2019)
• Table 145. Oncology Pharmaceuticals Sales: by Form(K Tons)
• Table 146. Oncology Pharmaceuticals Sales Tablets , by Region K Tons (2014-2019)
• Table 147. Oncology Pharmaceuticals Sales Capsules , by Region K Tons (2014-2019)
• Table 148. Oncology Pharmaceuticals Sales Others , by Region K Tons (2014-2019)
• Table 149. Oncology Pharmaceuticals Sales: by Distribution Channel(K Tons)
• Table 150. Oncology Pharmaceuticals Sales Online , by Region K Tons (2014-2019)
• Table 151. Oncology Pharmaceuticals Sales Offline [Hospital Pharmacy, Retail Pharmacy] , by Region K Tons (2014-2019)
• Table 152. South America Oncology Pharmaceuticals Sales, by Country K Tons (2014-2019)
• Table 153. South America Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 154. South America Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 155. South America Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 156. South America Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 157. Brazil Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 158. Brazil Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 159. Brazil Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 160. Brazil Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 161. Argentina Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 162. Argentina Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 163. Argentina Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 164. Argentina Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 165. Rest of South America Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 166. Rest of South America Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 167. Rest of South America Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 168. Rest of South America Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 169. Asia Pacific Oncology Pharmaceuticals Sales, by Country K Tons (2014-2019)
• Table 170. Asia Pacific Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 171. Asia Pacific Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 172. Asia Pacific Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 173. Asia Pacific Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 174. China Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 175. China Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 176. China Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 177. China Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 178. Japan Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 179. Japan Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 180. Japan Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 181. Japan Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 182. India Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 183. India Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 184. India Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 185. India Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 186. South Korea Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 187. South Korea Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 188. South Korea Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 189. South Korea Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 190. Taiwan Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 191. Taiwan Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 192. Taiwan Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 193. Taiwan Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 194. Australia Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 195. Australia Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 196. Australia Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 197. Australia Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 198. Rest of Asia-Pacific Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 199. Rest of Asia-Pacific Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 200. Rest of Asia-Pacific Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 201. Rest of Asia-Pacific Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 202. Europe Oncology Pharmaceuticals Sales, by Country K Tons (2014-2019)
• Table 203. Europe Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 204. Europe Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 205. Europe Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 206. Europe Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 207. Germany Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 208. Germany Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 209. Germany Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 210. Germany Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 211. France Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 212. France Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 213. France Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 214. France Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 215. Italy Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 216. Italy Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 217. Italy Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 218. Italy Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 219. United Kingdom Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 220. United Kingdom Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 221. United Kingdom Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 222. United Kingdom Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 223. Netherlands Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 224. Netherlands Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 225. Netherlands Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 226. Netherlands Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 227. Switzerland Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 228. Switzerland Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 229. Switzerland Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 230. Switzerland Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 231. Rest of Europe Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 232. Rest of Europe Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 233. Rest of Europe Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 234. Rest of Europe Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 235. MEA Oncology Pharmaceuticals Sales, by Country K Tons (2014-2019)
• Table 236. MEA Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 237. MEA Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 238. MEA Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 239. MEA Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 240. Middle East Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 241. Middle East Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 242. Middle East Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 243. Middle East Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 244. Africa Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 245. Africa Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 246. Africa Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 247. Africa Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 248. North America Oncology Pharmaceuticals Sales, by Country K Tons (2014-2019)
• Table 249. North America Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 250. North America Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 251. North America Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 252. North America Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 253. United States Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 254. United States Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 255. United States Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 256. United States Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 257. Canada Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 258. Canada Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 259. Canada Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 260. Canada Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 261. Mexico Oncology Pharmaceuticals Sales, by Type K Tons (2014-2019)
• Table 262. Mexico Oncology Pharmaceuticals Sales, by Application K Tons (2014-2019)
• Table 263. Mexico Oncology Pharmaceuticals Sales, by Form K Tons (2014-2019)
• Table 264. Mexico Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2014-2019)
• Table 265. Oncology Pharmaceuticals: by Type(USD/Units)
• Table 266. Company Basic Information, Sales Area and Its Competitors
• Table 267. Company Basic Information, Sales Area and Its Competitors
• Table 268. Company Basic Information, Sales Area and Its Competitors
• Table 269. Company Basic Information, Sales Area and Its Competitors
• Table 270. Company Basic Information, Sales Area and Its Competitors
• Table 271. Company Basic Information, Sales Area and Its Competitors
• Table 272. Company Basic Information, Sales Area and Its Competitors
• Table 273. Company Basic Information, Sales Area and Its Competitors
• Table 274. Company Basic Information, Sales Area and Its Competitors
• Table 275. Company Basic Information, Sales Area and Its Competitors
• Table 276. Company Basic Information, Sales Area and Its Competitors
• Table 277. Company Basic Information, Sales Area and Its Competitors
• Table 278. Company Basic Information, Sales Area and Its Competitors
• Table 279. Company Basic Information, Sales Area and Its Competitors
• Table 280. Company Basic Information, Sales Area and Its Competitors
• Table 281. Oncology Pharmaceuticals: by Type(USD Million)
• Table 282. Oncology Pharmaceuticals Chemotherapy , by Region USD Million (2020-2025)
• Table 283. Oncology Pharmaceuticals Targeted Therapy , by Region USD Million (2020-2025)
• Table 284. Oncology Pharmaceuticals Immunotherapy , by Region USD Million (2020-2025)
• Table 285. Oncology Pharmaceuticals Hormonal Therapy , by Region USD Million (2020-2025)
• Table 286. Oncology Pharmaceuticals Others , by Region USD Million (2020-2025)
• Table 287. Oncology Pharmaceuticals: by Application(USD Million)
• Table 288. Oncology Pharmaceuticals Breast Cancer , by Region USD Million (2020-2025)
• Table 289. Oncology Pharmaceuticals Blood Cancer , by Region USD Million (2020-2025)
• Table 290. Oncology Pharmaceuticals Colorectal , by Region USD Million (2020-2025)
• Table 291. Oncology Pharmaceuticals Melanoma , by Region USD Million (2020-2025)
• Table 292. Oncology Pharmaceuticals Others , by Region USD Million (2020-2025)
• Table 293. Oncology Pharmaceuticals: by Form(USD Million)
• Table 294. Oncology Pharmaceuticals Tablets , by Region USD Million (2020-2025)
• Table 295. Oncology Pharmaceuticals Capsules , by Region USD Million (2020-2025)
• Table 296. Oncology Pharmaceuticals Others , by Region USD Million (2020-2025)
• Table 297. Oncology Pharmaceuticals: by Distribution Channel(USD Million)
• Table 298. Oncology Pharmaceuticals Online , by Region USD Million (2020-2025)
• Table 299. Oncology Pharmaceuticals Offline [Hospital Pharmacy, Retail Pharmacy] , by Region USD Million (2020-2025)
• Table 300. South America Oncology Pharmaceuticals, by Country USD Million (2020-2025)
• Table 301. South America Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 302. South America Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 303. South America Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 304. South America Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 305. Brazil Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 306. Brazil Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 307. Brazil Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 308. Brazil Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 309. Argentina Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 310. Argentina Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 311. Argentina Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 312. Argentina Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 313. Rest of South America Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 314. Rest of South America Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 315. Rest of South America Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 316. Rest of South America Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 317. Asia Pacific Oncology Pharmaceuticals, by Country USD Million (2020-2025)
• Table 318. Asia Pacific Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 319. Asia Pacific Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 320. Asia Pacific Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 321. Asia Pacific Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 322. China Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 323. China Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 324. China Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 325. China Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 326. Japan Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 327. Japan Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 328. Japan Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 329. Japan Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 330. India Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 331. India Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 332. India Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 333. India Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 334. South Korea Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 335. South Korea Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 336. South Korea Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 337. South Korea Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 338. Taiwan Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 339. Taiwan Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 340. Taiwan Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 341. Taiwan Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 342. Australia Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 343. Australia Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 344. Australia Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 345. Australia Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 346. Rest of Asia-Pacific Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 347. Rest of Asia-Pacific Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 348. Rest of Asia-Pacific Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 349. Rest of Asia-Pacific Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 350. Europe Oncology Pharmaceuticals, by Country USD Million (2020-2025)
• Table 351. Europe Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 352. Europe Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 353. Europe Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 354. Europe Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 355. Germany Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 356. Germany Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 357. Germany Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 358. Germany Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 359. France Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 360. France Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 361. France Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 362. France Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 363. Italy Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 364. Italy Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 365. Italy Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 366. Italy Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 367. United Kingdom Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 368. United Kingdom Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 369. United Kingdom Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 370. United Kingdom Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 371. Netherlands Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 372. Netherlands Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 373. Netherlands Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 374. Netherlands Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 375. Switzerland Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 376. Switzerland Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 377. Switzerland Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 378. Switzerland Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 379. Rest of Europe Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 380. Rest of Europe Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 381. Rest of Europe Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 382. Rest of Europe Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 383. MEA Oncology Pharmaceuticals, by Country USD Million (2020-2025)
• Table 384. MEA Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 385. MEA Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 386. MEA Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 387. MEA Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 388. Middle East Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 389. Middle East Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 390. Middle East Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 391. Middle East Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 392. Africa Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 393. Africa Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 394. Africa Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 395. Africa Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 396. North America Oncology Pharmaceuticals, by Country USD Million (2020-2025)
• Table 397. North America Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 398. North America Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 399. North America Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 400. North America Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 401. United States Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 402. United States Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 403. United States Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 404. United States Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 405. Canada Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 406. Canada Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 407. Canada Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 408. Canada Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 409. Mexico Oncology Pharmaceuticals, by Type USD Million (2020-2025)
• Table 410. Mexico Oncology Pharmaceuticals, by Application USD Million (2020-2025)
• Table 411. Mexico Oncology Pharmaceuticals, by Form USD Million (2020-2025)
• Table 412. Mexico Oncology Pharmaceuticals, by Distribution Channel USD Million (2020-2025)
• Table 413. Oncology Pharmaceuticals Sales: by Type(K Tons)
• Table 414. Oncology Pharmaceuticals Sales Chemotherapy , by Region K Tons (2020-2025)
• Table 415. Oncology Pharmaceuticals Sales Targeted Therapy , by Region K Tons (2020-2025)
• Table 416. Oncology Pharmaceuticals Sales Immunotherapy , by Region K Tons (2020-2025)
• Table 417. Oncology Pharmaceuticals Sales Hormonal Therapy , by Region K Tons (2020-2025)
• Table 418. Oncology Pharmaceuticals Sales Others , by Region K Tons (2020-2025)
• Table 419. Oncology Pharmaceuticals Sales: by Application(K Tons)
• Table 420. Oncology Pharmaceuticals Sales Breast Cancer , by Region K Tons (2020-2025)
• Table 421. Oncology Pharmaceuticals Sales Blood Cancer , by Region K Tons (2020-2025)
• Table 422. Oncology Pharmaceuticals Sales Colorectal , by Region K Tons (2020-2025)
• Table 423. Oncology Pharmaceuticals Sales Melanoma , by Region K Tons (2020-2025)
• Table 424. Oncology Pharmaceuticals Sales Others , by Region K Tons (2020-2025)
• Table 425. Oncology Pharmaceuticals Sales: by Form(K Tons)
• Table 426. Oncology Pharmaceuticals Sales Tablets , by Region K Tons (2020-2025)
• Table 427. Oncology Pharmaceuticals Sales Capsules , by Region K Tons (2020-2025)
• Table 428. Oncology Pharmaceuticals Sales Others , by Region K Tons (2020-2025)
• Table 429. Oncology Pharmaceuticals Sales: by Distribution Channel(K Tons)
• Table 430. Oncology Pharmaceuticals Sales Online , by Region K Tons (2020-2025)
• Table 431. Oncology Pharmaceuticals Sales Offline [Hospital Pharmacy, Retail Pharmacy] , by Region K Tons (2020-2025)
• Table 432. South America Oncology Pharmaceuticals Sales, by Country K Tons (2020-2025)
• Table 433. South America Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 434. South America Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 435. South America Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 436. South America Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 437. Brazil Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 438. Brazil Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 439. Brazil Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 440. Brazil Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 441. Argentina Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 442. Argentina Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 443. Argentina Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 444. Argentina Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 445. Rest of South America Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 446. Rest of South America Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 447. Rest of South America Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 448. Rest of South America Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 449. Asia Pacific Oncology Pharmaceuticals Sales, by Country K Tons (2020-2025)
• Table 450. Asia Pacific Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 451. Asia Pacific Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 452. Asia Pacific Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 453. Asia Pacific Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 454. China Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 455. China Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 456. China Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 457. China Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 458. Japan Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 459. Japan Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 460. Japan Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 461. Japan Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 462. India Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 463. India Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 464. India Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 465. India Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 466. South Korea Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 467. South Korea Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 468. South Korea Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 469. South Korea Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 470. Taiwan Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 471. Taiwan Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 472. Taiwan Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 473. Taiwan Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 474. Australia Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 475. Australia Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 476. Australia Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 477. Australia Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 478. Rest of Asia-Pacific Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 479. Rest of Asia-Pacific Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 480. Rest of Asia-Pacific Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 481. Rest of Asia-Pacific Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 482. Europe Oncology Pharmaceuticals Sales, by Country K Tons (2020-2025)
• Table 483. Europe Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 484. Europe Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 485. Europe Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 486. Europe Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 487. Germany Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 488. Germany Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 489. Germany Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 490. Germany Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 491. France Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 492. France Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 493. France Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 494. France Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 495. Italy Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 496. Italy Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 497. Italy Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 498. Italy Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 499. United Kingdom Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 500. United Kingdom Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 501. United Kingdom Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 502. United Kingdom Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 503. Netherlands Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 504. Netherlands Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 505. Netherlands Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 506. Netherlands Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 507. Switzerland Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 508. Switzerland Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 509. Switzerland Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 510. Switzerland Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 511. Rest of Europe Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 512. Rest of Europe Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 513. Rest of Europe Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 514. Rest of Europe Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 515. MEA Oncology Pharmaceuticals Sales, by Country K Tons (2020-2025)
• Table 516. MEA Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 517. MEA Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 518. MEA Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 519. MEA Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 520. Middle East Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 521. Middle East Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 522. Middle East Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 523. Middle East Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 524. Africa Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 525. Africa Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 526. Africa Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 527. Africa Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 528. North America Oncology Pharmaceuticals Sales, by Country K Tons (2020-2025)
• Table 529. North America Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 530. North America Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 531. North America Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 532. North America Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 533. United States Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 534. United States Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 535. United States Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 536. United States Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 537. Canada Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 538. Canada Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 539. Canada Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 540. Canada Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 541. Mexico Oncology Pharmaceuticals Sales, by Type K Tons (2020-2025)
• Table 542. Mexico Oncology Pharmaceuticals Sales, by Application K Tons (2020-2025)
• Table 543. Mexico Oncology Pharmaceuticals Sales, by Form K Tons (2020-2025)
• Table 544. Mexico Oncology Pharmaceuticals Sales, by Distribution Channel K Tons (2020-2025)
• Table 545. Oncology Pharmaceuticals: by Type(USD/Units)
• Table 546. Research Programs/Design for This Report
• Table 547. Key Data Information from Secondary Sources
• Table 548. Key Data Information from Primary Sources

• Figure 1. Porters Five Forces
• Figure 2. Supply/Value Chain
• Figure 3. PESTEL analysis
• Figure 4. Global Oncology Pharmaceuticals: by Type USD Million (2014-2019)
• Figure 5. Global Oncology Pharmaceuticals: by Application USD Million (2014-2019)
• Figure 6. Global Oncology Pharmaceuticals: by Form USD Million (2014-2019)
• Figure 7. Global Oncology Pharmaceuticals: by Distribution Channel USD Million (2014-2019)
• Figure 8. South America Oncology Pharmaceuticals Share (%), by Country
• Figure 9. Asia Pacific Oncology Pharmaceuticals Share (%), by Country
• Figure 10. Europe Oncology Pharmaceuticals Share (%), by Country
• Figure 11. MEA Oncology Pharmaceuticals Share (%), by Country
• Figure 12. North America Oncology Pharmaceuticals Share (%), by Country
• Figure 13. Global Oncology Pharmaceuticals: by Type K Tons (2014-2019)
• Figure 14. Global Oncology Pharmaceuticals: by Application K Tons (2014-2019)
• Figure 15. Global Oncology Pharmaceuticals: by Form K Tons (2014-2019)
• Figure 16. Global Oncology Pharmaceuticals: by Distribution Channel K Tons (2014-2019)
• Figure 17. South America Oncology Pharmaceuticals Share (%), by Country
• Figure 18. Asia Pacific Oncology Pharmaceuticals Share (%), by Country
• Figure 19. Europe Oncology Pharmaceuticals Share (%), by Country
• Figure 20. MEA Oncology Pharmaceuticals Share (%), by Country
• Figure 21. North America Oncology Pharmaceuticals Share (%), by Country
• Figure 22. Global Oncology Pharmaceuticals: by Type USD/Units (2014-2019)
• Figure 23. Global Oncology Pharmaceuticals share by Players 2019 (%)
• Figure 24. Global Oncology Pharmaceuticals share by Players (Top 3) 2019(%)
• Figure 25. Global Oncology Pharmaceuticals share by Players (Top 5) 2019(%)
• Figure 26. BCG Matrix for key Companies
• Figure 27. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
• Figure 28. Roche Holding AG (Switzerland) Revenue: by Geography 2019
• Figure 29. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
• Figure 30. Eli Lilly and Company (United States) Revenue: by Geography 2019
• Figure 31. AbbVie, Inc. (United States) Revenue, Net Income and Gross profit
• Figure 32. AbbVie, Inc. (United States) Revenue: by Geography 2019
• Figure 33. Amgen Inc. (United States) Revenue, Net Income and Gross profit
• Figure 34. Amgen Inc. (United States) Revenue: by Geography 2019
• Figure 35. AstraZeneca plc. (United Kingdom) Revenue, Net Income and Gross profit
• Figure 36. AstraZeneca plc. (United Kingdom) Revenue: by Geography 2019
• Figure 37. Celgene Corporation (United States) Revenue, Net Income and Gross profit
• Figure 38. Celgene Corporation (United States) Revenue: by Geography 2019
• Figure 39. Sinopharm Group (China) Revenue, Net Income and Gross profit
• Figure 40. Sinopharm Group (China) Revenue: by Geography 2019
• Figure 41. Shanghai Pharmaceuticals Holding Co., Ltd. (China) Revenue, Net Income and Gross profit
• Figure 42. Shanghai Pharmaceuticals Holding Co., Ltd. (China) Revenue: by Geography 2019
• Figure 43. Gilead Sciences (United States) Revenue, Net Income and Gross profit
• Figure 44. Gilead Sciences (United States) Revenue: by Geography 2019
• Figure 45. CSPC pharmaceutical (China) Revenue, Net Income and Gross profit
• Figure 46. CSPC pharmaceutical (China) Revenue: by Geography 2019
• Figure 47. Jiangsu Hengrui Medicine (China) Revenue, Net Income and Gross profit
• Figure 48. Jiangsu Hengrui Medicine (China) Revenue: by Geography 2019
• Figure 49. Shanghai Fosun Pharmaceutical (China) Revenue, Net Income and Gross profit
• Figure 50. Shanghai Fosun Pharmaceutical (China) Revenue: by Geography 2019
• Figure 51. Guangzhou Hanfang Pharmaceutical Co., Ltd (China) Revenue, Net Income and Gross profit
• Figure 52. Guangzhou Hanfang Pharmaceutical Co., Ltd (China) Revenue: by Geography 2019
• Figure 53. China Meheco Group Co., Ltd (China) Revenue, Net Income and Gross profit
• Figure 54. China Meheco Group Co., Ltd (China) Revenue: by Geography 2019
• Figure 55. BeiGene (China) Revenue, Net Income and Gross profit
• Figure 56. BeiGene (China) Revenue: by Geography 2019
• Figure 57. Global Oncology Pharmaceuticals: by Type USD Million (2020-2025)
• Figure 58. Global Oncology Pharmaceuticals: by Application USD Million (2020-2025)
• Figure 59. Global Oncology Pharmaceuticals: by Form USD Million (2020-2025)
• Figure 60. Global Oncology Pharmaceuticals: by Distribution Channel USD Million (2020-2025)
• Figure 61. South America Oncology Pharmaceuticals Share (%), by Country
• Figure 62. Asia Pacific Oncology Pharmaceuticals Share (%), by Country
• Figure 63. Europe Oncology Pharmaceuticals Share (%), by Country
• Figure 64. MEA Oncology Pharmaceuticals Share (%), by Country
• Figure 65. North America Oncology Pharmaceuticals Share (%), by Country
• Figure 66. Global Oncology Pharmaceuticals: by Type K Tons (2020-2025)
• Figure 67. Global Oncology Pharmaceuticals: by Application K Tons (2020-2025)
• Figure 68. Global Oncology Pharmaceuticals: by Form K Tons (2020-2025)
• Figure 69. Global Oncology Pharmaceuticals: by Distribution Channel K Tons (2020-2025)
• Figure 70. South America Oncology Pharmaceuticals Share (%), by Country
• Figure 71. Asia Pacific Oncology Pharmaceuticals Share (%), by Country
• Figure 72. Europe Oncology Pharmaceuticals Share (%), by Country
• Figure 73. MEA Oncology Pharmaceuticals Share (%), by Country
• Figure 74. North America Oncology Pharmaceuticals Share (%), by Country
• Figure 75. Global Oncology Pharmaceuticals: by Type USD/Units (2020-2025)

• Roche Holding AG (Switzerland)
• Eli Lilly and Company (United States)
• AbbVie, Inc. (United States)
• Amgen Inc. (United States)
• AstraZeneca plc. (United Kingdom)
• Celgene Corporation (United States)
• Sinopharm Group (China)
• Shanghai Pharmaceuticals Holding Co., Ltd. (China)
• Gilead Sciences (United States)
• CSPC pharmaceutical (China)
• Jiangsu Hengrui Medicine (China)
• Shanghai Fosun Pharmaceutical (China)
• Guangzhou Hanfang Pharmaceutical Co., Ltd (China)
• China Meheco Group Co., Ltd (China)
• BeiGene (China)